492 related articles for article (PubMed ID: 28523533)
21. What is the impact of cervical invasion on lymph node metastasis in patients with stage IIIC endometrial cancer?
Turan T; Hızlı D; Yılmaz SS; Gundogdu B; Boran N; Tulunay G; Ozfuttu A; Faruk Kose M
Arch Gynecol Obstet; 2012 Apr; 285(4):1119-24. PubMed ID: 21898081
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas.
Karabagli P; Ugras S; Yilmaz BS; Celik C
Arch Gynecol Obstet; 2015 Aug; 292(2):391-7. PubMed ID: 25608758
[TBL] [Abstract][Full Text] [Related]
24. Is it possible to predict para-aortic lymph node metastasis in endometrial cancer?
Turan T; Hizli D; Sarici S; Boran N; Gundogdu B; Karadag B; Tulunay G; Kose MF
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):274-9. PubMed ID: 21664758
[TBL] [Abstract][Full Text] [Related]
25. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
Toprak S; Sahin EA; Sahin H; Tohma YA; Yilmaz E; Meydanli MM
Int J Gynaecol Obstet; 2021 Apr; 153(1):51-55. PubMed ID: 33118165
[TBL] [Abstract][Full Text] [Related]
27. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
28. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
29. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract][Full Text] [Related]
30. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
[TBL] [Abstract][Full Text] [Related]
31. Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis.
Baiocchi G; Faloppa CC; Mantoan H; Camarço WR; Badiglian-Filho L; Kumagai LY; De Brot L; da Costa AABA
J Surg Oncol; 2017 Aug; 116(2):220-226. PubMed ID: 28482122
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
33. Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.
Korkmaz V; Meydanli MM; Yalçın I; Sarı ME; Sahin H; Kocaman E; Haberal A; Dursun P; Güngör T; Ayhan A
J Gynecol Oncol; 2017 Nov; 28(6):e78. PubMed ID: 29027396
[TBL] [Abstract][Full Text] [Related]
34. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.
Kumar S; Podratz KC; Bakkum-Gamez JN; Dowdy SC; Weaver AL; McGree ME; Cliby WA; Keeney GL; Thomas G; Mariani A
Gynecol Oncol; 2014 Jan; 132(1):38-43. PubMed ID: 24120926
[TBL] [Abstract][Full Text] [Related]
35. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.
Multinu F; Casarin J; Cappuccio S; Keeney GL; Glaser GE; Cliby WA; Weaver AL; McGree ME; Angioni S; Faa G; Leitao MM; Abu-Rustum NR; Mariani A
Gynecol Oncol; 2019 Jul; 154(1):60-64. PubMed ID: 31126637
[TBL] [Abstract][Full Text] [Related]
36. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
37. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
[TBL] [Abstract][Full Text] [Related]
38. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
39. Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution study.
Pifer PM; Bhargava R; Patel AK; Ling DC; Vargo JA; Orr BC; Sukumvanich P; Courtney-Brooks MB; Boisen MM; Berger JL; Taylor S; Olawaiye AB; Comerci JT; Lesnock JL; Edwards RP; Beriwal S
Gynecol Oncol; 2020 Oct; 159(1):23-29. PubMed ID: 32718729
[TBL] [Abstract][Full Text] [Related]
40. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.
Boren T; Lea J; Kehoe S; Miller DS; Richardson D
Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
